Status:

COMPLETED

Cerebroplacental Ratio and Perinatal Outcomes in Mild and Moderate Idiopathic Polyhydramios Cases

Lead Sponsor:

Necmettin Erbakan University

Conditions:

Idiopathic Polyhydramios Cases

Eligibility:

FEMALE

18-45 years

Brief Summary

This study aims to evaluate the predictability of fetal Doppler parameters in terms of perinatal adverse outcomes in singleton pregnancies with mild and moderate idiopathic polyhydramnios

Detailed Description

Pregnant women diagnosed with mild-moderate IP and randomly selected low-risk singleton pregnancies without polyhydramnios were included in the study one-on-one by matching their gestational ages. The...

Eligibility Criteria

Inclusion

  • Pregnant women diagnosed with mild-moderate IP ,selected low-risk singleton pregnancies without polyhydramnios

Exclusion

  • Women who had chromosomal or anatomical abnormalities, multiple pregnancies, oligohydramnios (AFI 5 cm), severe polyhydramnios, fetal growth restriction, elective cesarean section (CS), pre-existing conditions (hypertension, diabetes, thrombophilia), or obstetric complications (gestational hypertension, preeclampsia, gestational diabetes) were excluded

Key Trial Info

Start Date :

January 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 30 2023

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT06211855

Start Date

January 1 2023

End Date

November 30 2023

Last Update

January 18 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Necmettin Erbakan University

Meram, Konya, Turkey (Türkiye), 42140